444 related articles for article (PubMed ID: 18503613)
1. Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components.
Grellier P; Benach J; Labaied M; Charneau S; Gil H; Monsalve G; Alfonso R; Sawyer L; Lin L; Steiert M; Dupuis K
Transfusion; 2008 Aug; 48(8):1676-84. PubMed ID: 18503613
[TBL] [Abstract][Full Text] [Related]
2. Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment.
Lin L; Conlan MG; Tessman J; Cimino G; Porter S
Transfusion; 2005 Oct; 45(10):1610-20. PubMed ID: 16181212
[TBL] [Abstract][Full Text] [Related]
3. Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model.
Jordan CT; Saakadze N; Newman JL; Lezhava LJ; Maiers TT; Hillyer WM; Roback JD; Hillyer CD
Transfusion; 2004 Aug; 44(8):1159-65. PubMed ID: 15265119
[TBL] [Abstract][Full Text] [Related]
4. In vitro photochemical inactivation of cell-associated human T-cell leukemia virus Type I and II in human platelet concentrates and plasma by use of amotosalen.
Jauvin V; Alfonso RD; Guillemain B; Dupuis K; Fleury HJ
Transfusion; 2005 Jul; 45(7):1151-9. PubMed ID: 15987361
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of photochemical treatment with amotosalen HCl and ultraviolet A (INTERCEPT) for inactivation of Trypanosoma cruzi in pooled buffy-coat platelets.
Castro E; Gironés N; Bueno JL; Carrión J; Lin L; Fresno M
Transfusion; 2007 Mar; 47(3):434-41. PubMed ID: 17319823
[TBL] [Abstract][Full Text] [Related]
6. Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria.
Lin L; Dikeman R; Molini B; Lukehart SA; Lane R; Dupuis K; Metzel P; Corash L
Transfusion; 2004 Oct; 44(10):1496-504. PubMed ID: 15383024
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Mirasol pathogen [corrected] reduction technology system against Babesia microti in apheresis platelets and plasma.
Tonnetti L; Proctor MC; Reddy HL; Goodrich RP; Leiby DA
Transfusion; 2010 May; 50(5):1019-27. PubMed ID: 20030791
[TBL] [Abstract][Full Text] [Related]
8. Pathogen inactivation of platelets with a photochemical treatment with amotosalen HCl and ultraviolet light: process used in the SPRINT trial.
Pineda A; McCullough J; Benjamin RJ; Cable R; Strauss RG; Burgstaler E; Porter S; Lin L; Metzel P; Conlan MG;
Transfusion; 2006 Apr; 46(4):562-71. PubMed ID: 16584432
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination.
Sawyer L; Hanson D; Castro G; Luckett W; Dubensky TW; Stassinopoulos A
Transfusion; 2007 Jun; 47(6):1062-70. PubMed ID: 17524098
[TBL] [Abstract][Full Text] [Related]
10. Assessment of safety in neonates for transfusion of platelets and plasma prepared with amotosalen photochemical pathogen inactivation treatment by a 1-month intravenous toxicity study in neonatal rats.
Ciaravino V; Hanover J; Lin L; Sullivan T; Corash L
Transfusion; 2009 May; 49(5):985-94. PubMed ID: 19175545
[TBL] [Abstract][Full Text] [Related]
11. Leishmania inactivation in human pheresis platelets by a psoralen (amotosalen HCl) and long-wavelength ultraviolet irradiation.
Eastman RT; Barrett LK; Dupuis K; Buckner FS; Van Voorhis WC
Transfusion; 2005 Sep; 45(9):1459-63. PubMed ID: 16131378
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of Babesia microti in red blood cells and platelet concentrates.
Tonnetti L; Laughhunn A; Thorp AM; Vasilyeva I; Dupuis K; Stassinopoulos A; Stramer SL
Transfusion; 2017 Oct; 57(10):2404-2412. PubMed ID: 28872685
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of in vitro storage properties of prestorage pooled whole blood-derived platelets suspended in 100 percent plasma and treated with amotosalen and long-wavelength ultraviolet light.
Wagner SJ; Skripchenko A; Myrup A; Awatefe H; Thompson-Montgomery D; Moroff G; Carmichael P; Lin L
Transfusion; 2009 Apr; 49(4):704-10. PubMed ID: 19171001
[TBL] [Abstract][Full Text] [Related]
14. Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers.
Schlenke P; Hervig T; Isola H; Wiesel ML; Kientz D; Pinkoski L; Singh Y; Lin L; Corash L; Cazenave JP
Transfusion; 2008 Apr; 48(4):697-705. PubMed ID: 18194378
[TBL] [Abstract][Full Text] [Related]
15. Polymerase chain reaction inhibition assay documenting the amotosalen-based photochemical pathogen inactivation process of platelet concentrates.
Bruchmüller I; Janetzko K; Bugert P; Mayaudon V; Corash L; Lin L; Klüter H
Transfusion; 2005 Sep; 45(9):1464-72. PubMed ID: 16131379
[TBL] [Abstract][Full Text] [Related]
16. Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.
Janetzko K; Lin L; Eichler H; Mayaudon V; Flament J; Klüter H
Vox Sang; 2004 May; 86(4):239-45. PubMed ID: 15144528
[TBL] [Abstract][Full Text] [Related]
17. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial.
Snyder E; McCullough J; Slichter SJ; Strauss RG; Lopez-Plaza I; Lin JS; Corash L; Conlan MG;
Transfusion; 2005 Dec; 45(12):1864-75. PubMed ID: 16371039
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of Plasmodium spp. in plasma and platelet concentrates using riboflavin and ultraviolet light.
Keil SD; Kiser P; Sullivan JJ; Kong AS; Reddy HL; Avery A; Goodrich RP
Transfusion; 2013 Oct; 53(10):2278-86. PubMed ID: 23320495
[TBL] [Abstract][Full Text] [Related]
19. Riboflavin and ultraviolet light reduce the infectivity of Babesia microti in whole blood.
Tonnetti L; Thorp AM; Reddy HL; Keil SD; Goodrich RP; Leiby DA
Transfusion; 2013 Apr; 53(4):860-7. PubMed ID: 22803831
[TBL] [Abstract][Full Text] [Related]
20. The role of photochemical treatment with amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infections.
Roback JD; Conlan M; Drew WL; Ljungman P; Nichols WG; Preiksaitis JK
Transfus Med Rev; 2006 Jan; 20(1):45-56. PubMed ID: 16373187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
